RxSight is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. Co.'s proprietary RxSight Light Adjustable Lens system, comprised of RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and accessories, is the first commercially available intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. Co.'s LAL is made of proprietary photosensitive material that changes shape in response to specific patterns of ultraviolet light generated by Co.'s LDD. The RXST stock yearly return is shown above.
The yearly return on the RXST stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the RXST annual return calculation with any dividends reinvested as applicable (on ex-dates).
|